Glutamine in the pathogenesis of acute hepatic encephalopathy

Kakulavarapu V. Rama Rao, Arumugam R. Jayakumar, Michael D Norenberg

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Hepatic encephalopathy (HE) is the major neurological disorder associated with liver disease. It presents in chronic and acute forms, and astrocytes are the major neural cells involved. While the principal etiological factor in the pathogenesis of HE is increased levels of blood and brain ammonia, glutamine, a byproduct of ammonia metabolism, has also been implicated in its pathogenesis. This article reviews the current status of glutamine in the pathogenesis of HE, particularly its involvement in some of the events triggered by ammonia, including mitochondrial dysfunction, generation of oxidative stress, and alterations in signaling mechanisms, including activation of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB). Mechanisms by which glutamine contributes to astrocyte swelling/brain edema associated with acute liver failure (ALF) will also be described.

Original languageEnglish
Pages (from-to)575-580
Number of pages6
JournalNeurochemistry International
Volume61
Issue number4
DOIs
StatePublished - Sep 1 2012

Fingerprint

Hepatic Encephalopathy
Glutamine
Ammonia
Astrocytes
Acute Liver Failure
Brain Edema
Mitogen-Activated Protein Kinases
Nervous System Diseases
Liver Diseases
Oxidative Stress
Brain

Keywords

  • Acute liver failure
  • Ammonia
  • Astrocytes
  • Glutamine
  • Hepatic encephalopathy
  • Histidine
  • Mitochondria
  • Mitochondrial permeability transition
  • Oxidative stress

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Cell Biology

Cite this

Glutamine in the pathogenesis of acute hepatic encephalopathy. / Rama Rao, Kakulavarapu V.; Jayakumar, Arumugam R.; Norenberg, Michael D.

In: Neurochemistry International, Vol. 61, No. 4, 01.09.2012, p. 575-580.

Research output: Contribution to journalArticle

Rama Rao, Kakulavarapu V. ; Jayakumar, Arumugam R. ; Norenberg, Michael D. / Glutamine in the pathogenesis of acute hepatic encephalopathy. In: Neurochemistry International. 2012 ; Vol. 61, No. 4. pp. 575-580.
@article{a70ee1a3f871434bb55327cbc4ab7f99,
title = "Glutamine in the pathogenesis of acute hepatic encephalopathy",
abstract = "Hepatic encephalopathy (HE) is the major neurological disorder associated with liver disease. It presents in chronic and acute forms, and astrocytes are the major neural cells involved. While the principal etiological factor in the pathogenesis of HE is increased levels of blood and brain ammonia, glutamine, a byproduct of ammonia metabolism, has also been implicated in its pathogenesis. This article reviews the current status of glutamine in the pathogenesis of HE, particularly its involvement in some of the events triggered by ammonia, including mitochondrial dysfunction, generation of oxidative stress, and alterations in signaling mechanisms, including activation of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB). Mechanisms by which glutamine contributes to astrocyte swelling/brain edema associated with acute liver failure (ALF) will also be described.",
keywords = "Acute liver failure, Ammonia, Astrocytes, Glutamine, Hepatic encephalopathy, Histidine, Mitochondria, Mitochondrial permeability transition, Oxidative stress",
author = "{Rama Rao}, {Kakulavarapu V.} and Jayakumar, {Arumugam R.} and Norenberg, {Michael D}",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.neuint.2012.01.012",
language = "English",
volume = "61",
pages = "575--580",
journal = "Neurochemistry International",
issn = "0197-0186",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Glutamine in the pathogenesis of acute hepatic encephalopathy

AU - Rama Rao, Kakulavarapu V.

AU - Jayakumar, Arumugam R.

AU - Norenberg, Michael D

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Hepatic encephalopathy (HE) is the major neurological disorder associated with liver disease. It presents in chronic and acute forms, and astrocytes are the major neural cells involved. While the principal etiological factor in the pathogenesis of HE is increased levels of blood and brain ammonia, glutamine, a byproduct of ammonia metabolism, has also been implicated in its pathogenesis. This article reviews the current status of glutamine in the pathogenesis of HE, particularly its involvement in some of the events triggered by ammonia, including mitochondrial dysfunction, generation of oxidative stress, and alterations in signaling mechanisms, including activation of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB). Mechanisms by which glutamine contributes to astrocyte swelling/brain edema associated with acute liver failure (ALF) will also be described.

AB - Hepatic encephalopathy (HE) is the major neurological disorder associated with liver disease. It presents in chronic and acute forms, and astrocytes are the major neural cells involved. While the principal etiological factor in the pathogenesis of HE is increased levels of blood and brain ammonia, glutamine, a byproduct of ammonia metabolism, has also been implicated in its pathogenesis. This article reviews the current status of glutamine in the pathogenesis of HE, particularly its involvement in some of the events triggered by ammonia, including mitochondrial dysfunction, generation of oxidative stress, and alterations in signaling mechanisms, including activation of mitogen-activated protein kinases (MAPKs) and nuclear factor-kappaB (NF-κB). Mechanisms by which glutamine contributes to astrocyte swelling/brain edema associated with acute liver failure (ALF) will also be described.

KW - Acute liver failure

KW - Ammonia

KW - Astrocytes

KW - Glutamine

KW - Hepatic encephalopathy

KW - Histidine

KW - Mitochondria

KW - Mitochondrial permeability transition

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=84865797225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865797225&partnerID=8YFLogxK

U2 - 10.1016/j.neuint.2012.01.012

DO - 10.1016/j.neuint.2012.01.012

M3 - Article

C2 - 22285152

AN - SCOPUS:84865797225

VL - 61

SP - 575

EP - 580

JO - Neurochemistry International

JF - Neurochemistry International

SN - 0197-0186

IS - 4

ER -